The prototype of EPID-based in vivo dose verification for VMAT treatments in patients with prostate cancer.

MLA

Ślosarek, Krzysztof, et al. “The Prototype of EPID-Based in Vivo Dose Verification for VMAT Treatments in Patients with Prostate Cancer.” Nowotwory, vol. 73, no. 1, Jan. 2023, pp. 10–17. EBSCOhost, https://doi.org/10.5603/NJO.a2023.0002.

APA

Ślosarek, K., Gądek, A., Reudelsdorf-Ullmann, M., Sroka, Ł., & Winiecki, J. (2023). The prototype of EPID-based in vivo dose verification for VMAT treatments in patients with prostate cancer. Nowotwory, 73(1), 10–17. https://doi.org/10.5603/NJO.a2023.0002

Chicago

Ślosarek, Krzysztof, Adam Gądek, Marta Reudelsdorf-Ullmann, Łukasz Sroka, and Janusz Winiecki. 2023. “The Prototype of EPID-Based in Vivo Dose Verification for VMAT Treatments in Patients with Prostate Cancer.” Nowotwory 73 (1): 10–17. doi:10.5603/NJO.a2023.0002.